☆ 4.7 Article

Clinical implications of circulating follistatin-like protein-1 in hemodialysis patients

SCIENTIFIC REPORTS (2023)

Related references

Note: Only part of the references are listed.

Review Geriatrics & Gerontology

Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta-analysis

Xiaoyu Shu et al.

Summary: There is no consensus on the prevalence and impact of sarcopenia in patients with end-stage renal disease undergoing dialysis. This review aimed to summarize the diagnostic criteria, prevalence, and impact of sarcopenia on mortality in these patients. The results showed that sarcopenia is highly prevalent in dialysis patients and is associated with increased mortality risk. Standardization of diagnostic criteria for sarcopenia is necessary, and further longitudinal studies are needed to investigate its prevalence and prognostic value in dialysis patients.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)

Add to Collection

Review Pharmacology & Pharmacy

Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease

Yinghui Wang et al.

Summary: Chronic kidney disease and cardiac insufficiency often co-exist, especially in uremic patients on hemodialysis. Impaired renal function is often indicative of poor prognosis in patients with cardiac insufficiency. Inflammation plays a significant role in the development of cardiovascular complications in patients with chronic kidney disease and is indicative of prognosis.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Circulating Neprilysin Level Predicts the Risk of Cardiovascular Events in Hemodialysis Patients

Hyeon Seok Hwang et al.

Summary: In hemodialysis patients, circulating neprilysin levels were found to be positively correlated with left ventricular mass index and volumes, and negatively correlated with left ventricular ejection fraction. Higher levels of neprilysin independently predicted the occurrence of cardiovascular and cardiac events in these patients, highlighting the potential importance of neprilysin inhibition in reducing cardiovascular events.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Circulating Vascular Adhesion Protein-1 Level Predicts the Risk of Cardiovascular Events and Mortality in Hemodialysis Patients

Dae Kyu Kim et al.

Summary: In hemodialysis patients, plasma VAP-1 levels are positively correlated with plasma levels of cardiac remodeling markers and higher levels are associated with left ventricular diastolic dysfunction. Patients with higher circulating VAP-1 levels have an increased risk of incident cardiovascular and cardiac events, suggesting that VAP-1 may help clinicians identify HD patients at high risk of cardiovascular events.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Add to Collection

Review Urology & Nephrology

Sarcopenia in chronic kidney disease: what have we learned so far?

Alice Sabatino et al.

Summary: Sarcopenia, initially defined as muscle loss in elderly by Irwin Rosenberg in 1988, has now evolved to encompass not only muscle mass loss but also strength and physical performance decline in consensus papers. In CKD, sarcopenia is prevalent not just due to aging, but also accelerated protein breakdown from the disease and dialysis, associated with worse clinical outcomes.

JOURNAL OF NEPHROLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prognostic impact of transcardiac gradient of follistatin-like 1 reflecting hemodynamics in patients with dilated cardiomyopathy

Hideo Oishi et al.

Summary: This study suggests that the transcardiac gradient of FSTL1 may serve as a novel prognostic predictor in patients with dilated cardiomyopathy, with a negative gradient potentially indicating impaired hemodynamics and increased risk of cardiac events.

JOURNAL OF CARDIOLOGY (2021)

Add to Collection

Review Chemistry, Multidisciplinary

Cytokines: From Clinical Significance to Quantification

Chao Liu et al.

Summary: Cytokines play a critical role in regulating immune and inflammatory responses, serving as biomarkers for many diseases. Quantification of cytokines provides valuable insights into physiological and pathological processes for diagnosis and treatment in both clinical medicine and biology. Advances in in vitro and in vivo assays, biosensors, and quantification platforms aim to achieve real-time multiplex cytokine analysis for biomedical research and clinical practice.

ADVANCED SCIENCE (2021)

Add to Collection

Article Medicine, General & Internal

Circulating PCSK9 Level and Risk of Cardiovascular Events and Death in Hemodialysis Patients

Hyeon Seok Hwang et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Article Urology & Nephrology

Gait speed and handgrip strength as predictors of all-cause mortality and cardiovascular events in hemodialysis patients

Yu Ho Lee et al.

BMC NEPHROLOGY (2020)

Add to Collection

Review Immunology

Molecular functions of FSTL1 in the osteoarthritis

Wencui Li et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2020)

Add to Collection

Review Nutrition & Dietetics

Uremic Sarcopenia: Clinical Evidence and Basic Experimental Approach

Hiroshi Nishi et al.

NUTRIENTS (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Follistatin-like 1 in development and human diseases

Andrea Mattiotti et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2018)

Add to Collection

Review Transplantation

Cardiovascular disease in dialysis patients

Mario Cozzolino et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)

Add to Collection

Article Urology & Nephrology

Quality of life as indicator of poor outcome in hemodialysis: relation with mortality in different age groups

I. N. van Loon et al.

BMC NEPHROLOGY (2017)

Add to Collection

Article Medicine, Research & Experimental

Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture

Sonomi Maruyama et al.

EMBO MOLECULAR MEDICINE (2016)

Add to Collection

Review Microbiology

IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections

Jeroen Slaats et al.

PLOS PATHOGENS (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Roberto M. Lang et al.

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2015)

Add to Collection

Article Immunology

Follistatin-like protein 1 and its role in inflammation and inflammatory diseases

Yury Chaly et al.

IMMUNOLOGIC RESEARCH (2014)

Add to Collection

Review Geriatrics & Gerontology

Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia

Liang-Kung Chen et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Regulation of follistatin-like protein 1 expression and secretion in primary human skeletal muscle cells

Sven W. Goergens et al.

ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2013)

Add to Collection

Article Urology & Nephrology

The Relationship between Carotid Atherosclerosis, Inflammatory Cytokines, and Oxidative Stress in Middle-Aged and Elderly Hemodialysis Patients

Hongqi Ren et al.

INTERNATIONAL JOURNAL OF NEPHROLOGY (2013)

Add to Collection

Article Cardiac & Cardiovascular Systems

Therapeutic Impact of Follistatin-Like 1 on Myocardial Ischemic Injury in Preclinical Models

Yasuhiro Ogura et al.

CIRCULATION (2012)

Add to Collection

Article Cardiac & Cardiovascular Systems

Follistatin-Like 1 in Chronic Systolic Heart Failure A Marker of Left Ventricular Remodeling

Ali El-Armouche et al.

CIRCULATION-HEART FAILURE (2011)

Add to Collection

Article Multidisciplinary Sciences

The BMP Antagonist Follistatin-Like 1 Is Required for Skeletal and Lung Organogenesis

Marc Sylva et al.

PLOS ONE (2011)

Add to Collection

Article Multidisciplinary Sciences

Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload

Masayuki Shimano et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Add to Collection

Article Rheumatology

Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis

Dawei Li et al.

ARTHRITIS RESEARCH & THERAPY (2011)

Add to Collection

Article Medical Laboratory Technology

Circulating Concentrations of Follistatin-Like 1 in Healthy Individuals and Patients with Acute Coronary Syndrome as Assessed by an Immunoluminometric Sandwich Assay

Christian Widera et al.

CLINICAL CHEMISTRY (2009)

Add to Collection

Review Biochemistry & Molecular Biology

Monocyte Chemoattractant Protein-1 (MCP-1): An Overview

Satish L. Deshmane et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2009)

Add to Collection

Article Urology & Nephrology

Cognitive impairment in the aging dialysis and chronic kidney disease populations: An occult burden

Anne M. Murray

ADVANCES IN CHRONIC KIDNEY DISEASE (2008)

Add to Collection

Review Biochemistry & Molecular Biology

MicroRNA-206: The skeletal muscle-specific myomiR

John J. McCarthy

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2008)

Add to Collection

Article Cardiac & Cardiovascular Systems

Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart

Yuichi Oshima et al.

CIRCULATION (2008)

Add to Collection

Article Biochemistry & Molecular Biology

Follistatin-like 1, a Secreted Muscle Protein, Promotes Endothelial Cell Function and Revascularization in Ischemic Tissue through a Nitric-oxide Synthase-dependent Mechanism

Noriyuki Ouchi et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Add to Collection

Article Urology & Nephrology

Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients

AK Cheung et al.

KIDNEY INTERNATIONAL (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.